Vaccine Therapy in Treating Patients With Breast Cancer

NCT00524277 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

456

Enrollment

FED

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: GP2 peptide + GM-CSF vaccine
BIOLOGICAL: GM-CSF (sargramostim)
BIOLOGICAL: AE37 + GM-CSF vaccine
BIOLOGICAL: GM-CSF (sargramostim)

Sponsor

San Antonio Military Medical Center

Collaborators

[object Object]
[object Object]